( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1065.4
1354.2
1457.2
1550.7
Total Expenditure
1132
1550.8
1604.6
1736.3
PBIDT (Excl OI)
-66.59
-196.6
-147.4
-185.6
Other Income
30.1
11.9
9.8
36.3
Operating Profit
-36.5
-184.7
-137.6
-149.3
Interest
89.8
94.9
130.8
116.8
Exceptional Items
5.1
45.8
630.3
NA
PBDT
-121.2
-233.8
361.9
-266.1
Depreciation
71.3
75.3
84.3
86
Profit Before Tax
-192.5
-309.1
277.6
-352.1
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-153.2
-251.3
407.6
-278.4
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-153.2
-251.3
407.6
-278.4
Minority Interest
NA
NA
NA
NA
Shares of Associates
39.8
81.2
-14.1
16.4
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-113.4
-170.1
393.5
-262
Equity Capital
48.2
48.2
48.2
48.2
Face Value (IN RS)
10
10
10
10
Calculated EPS
-23.52
-35.29
81.63
-54.35
Calculated EPS (Annualised)
-94.10
-141.16
326.55
-217.42
No of Public Share Holdings
1276601
1276601
1276601
1276601
% of Public Share Holdings
26.51
26.49
26.51
26.49
PBIDTM% (Excl OI)
-6.25
-14.51
-10.11
-11.96
PBIDTM%
-3.42
-13.63
-9.44
-9.62
PBDTM%
-11.37
-17.26
24.83
-17.15
PBTM%
-18.06
-22.82
19.05
-22.70
PATM%
-14.37
-18.55
27.97
-17.95